Company Filing History:
Years Active: 2017
Title: Lenore Von Krusenstiern: Innovator in Lipoprotein Lipase Therapy
Introduction
Lenore Von Krusenstiern is a prominent inventor based in Brookline, MA (US). She has made significant contributions to the field of medical therapies, particularly in the treatment of hypertriglyceridemic-related conditions. Her innovative work has the potential to impact many lives suffering from related diseases.
Latest Patents
Lenore holds a patent for a lipoprotein lipase (LPL) protein aimed at treating and preventing hypertriglyceridemia (HTG) and its associated diseases. This includes conditions such as acute pancreatitis, cardiovascular and metabolic diseases, endocrine disorders, and fat embolism syndrome. Her patent represents a crucial advancement in the medical field, providing new avenues for treatment.
Career Highlights
Lenore is currently associated with Shire Human Genetic Therapies, Inc., where she continues to develop her groundbreaking work. Her dedication to research and innovation has established her as a key figure in her field.
Collaborations
Lenore has collaborated with notable colleagues, including Omar L Francone and Lin Guey. These partnerships have further enhanced her research and development efforts.
Conclusion
Lenore Von Krusenstiern's contributions to lipoprotein lipase therapy exemplify her commitment to advancing medical science. Her innovative patent and collaborative efforts position her as a leading inventor in the treatment of hypertriglyceridemic-related conditions.